{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T03:35:21Z","timestamp":1776483321473,"version":"3.51.2"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Stem Cell Research"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.scr.2024.103582","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T11:06:21Z","timestamp":1729076781000},"page":"103582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Patient-derived induced pluripotent stem cells to study non-canonical splicing variants associated with Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"81","author":[{"given":"Joanna","family":"Jager","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Furtado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petros","family":"Syrris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis R.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perry M.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim M.S.","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Carmo-Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sim\u00e3o Teixeira","family":"da Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7733-4485","authenticated-orcid":false,"given":"Sandra","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.scr.2024.103582_b0005","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad194","article-title":"ESC Guidelines for the management of cardiomyopathies","author":"Arbelo","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.scr.2024.103582_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2018.04.078","article-title":"Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic Cardiomyopathy","author":"Bagnall","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.scr.2024.103582_b0020","article-title":"Computational prediction of human deep intronic variation","author":"Barbosa","year":"2023","journal-title":"GigaScience"},{"key":"10.1016\/j.scr.2024.103582_b0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910401","article-title":"Genetic Testing in Patients with Hypertrophic Cardiomyopathy","author":"Bonaventura","year":"2021","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.scr.2024.103582_b0030","doi-asserted-by":"crossref","unstructured":"Branco MA, Cotovio JP, Rodrigues CAV, Vaz SH, Fernandes TG, Moreira LM, Cabral JMS, Diogo MM. Transcriptomic analysis of 3D Cardiac Differentiation of Human Induced Pluripotent Stem Cells Reveals Faster Cardiomyocyte Maturation Compared to 2D Culture (2019) Sci Rep. https:\/\/doi: 10.1038\/s41598-019-45047-9.","DOI":"10.1038\/s41598-019-45047-9"},{"key":"10.1016\/j.scr.2024.103582_b0035","series-title":"Hypertrophic Cardiomyopathy","first-page":"1","article-title":"Hypertrophic cardiomyopathy: The past, the present, and the future","author":"Braunwald","year":"2015"},{"key":"10.1016\/j.scr.2024.103582_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11102801","article-title":"Identifying Potent Nonsense-Mediated mRNA Decay Inhibitors with a Novel Screening System","author":"Carrard","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.scr.2024.103582_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.xgen.2023.100445","article-title":"Harnessing human genetics and stem cells for precision cardiovascular medicine","author":"Caudal","year":"2024","journal-title":"Cell Genom"},{"key":"10.1016\/j.scr.2024.103582_b0055","article-title":"Advances in Hypertrophic Cardiomyopathy Disease Modeling using Human iPSC-derived Cardiomyocytes","author":"Dababneh","year":"2023","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.scr.2024.103582_b0060","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","author":"Elliott","year":"2014","journal-title":"Eur Heart J."},{"key":"10.1016\/j.scr.2024.103582_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17111883","article-title":"Functional Studies and In Silico Analyses to Evaluate Non-Coding Variants in Inherited Cardiomyopathies","author":"Frisso","year":"2016","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.scr.2024.103582_b0070","doi-asserted-by":"crossref","DOI":"10.1007\/s00204-021-03172-3","article-title":"Recent progress of iPSC technology in cardiac diseases","author":"Funakoshi","year":"2021","journal-title":"Arch Toxicol."},{"key":"10.1016\/j.scr.2024.103582_b0080","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133782","article-title":"Effects of MYBPC3 loss-of-function mutations preceding hypertrophic cardiomyopathy","author":"Helms","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.scr.2024.103582_b0085","doi-asserted-by":"crossref","DOI":"10.1007\/s12265-009-9124-7","article-title":"Hypertrophic cardiomyopathy: preclinical and early phenotype","author":"Ho","year":"2009","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.scr.2024.103582_b0090","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003202","article-title":"Transcriptome Sequencing of Patients With Hypertrophic Cardiomyopathy Reveals Novel Splice-Altering Variants in MYBPC3","author":"Holliday","year":"2021","journal-title":"Circ Genom Precis Med."},{"key":"10.1016\/j.scr.2024.103582_b0095","article-title":"Human Pluripotent Stem Cell-Derived Cardiac Cells: Application in Disease Modeling, Cell Therapy, and Drug Discovery","author":"Huang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.scr.2024.103582_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/S0092-8674(01)00475-5","article-title":"Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20","author":"Ishigaki","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.scr.2024.103582_b0105","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1707741114","article-title":"Identification of pathogenic gene mutations in LMNA and MYBPC3 that alter RNA splicing","author":"Ito","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.scr.2024.103582_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.12.015","article-title":"Predicting Splicing from Primary Sequence with Deep Learning","author":"Jaganathan","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.scr.2024.103582_b0115","doi-asserted-by":"crossref","unstructured":"Jin J, Lu L, Chen J, Wang K, Han J, Xue S, Weng G. Generation of an induced pluripotential stem cell (iPSC) line from a patient with hypertrophic cardiomyopathy carrying myosin binding protein C (MYBPC3) c.3369-3370 insC mutation (2020) Stem Cell Res. doi: 10.1016\/j.scr.2020.102144.","DOI":"10.1016\/j.scr.2020.102144"},{"key":"10.1016\/j.scr.2024.103582_b0120","article-title":"Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells","author":"Li","year":"2022","journal-title":"Stem Cell Res Ther."},{"key":"10.1016\/j.scr.2024.103582_b0125","article-title":"Generation of two heterozygous MYBPC3 mutation-carrying human iPSC lines, SCVIi001-A and SCVIi002-A, for modeling hypertrophic cardiomyopathy","author":"Liu","year":"2021","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.scr.2024.103582_b0130","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.002905","article-title":"Cryptic Splice-Altering Variants in MYBPC3 Are a Prevalent Cause of Hypertrophic Cardiomyopathy","author":"Lopes","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.scr.2024.103582_b0135","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae421","article-title":"Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice","author":"Lopes","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.scr.2024.103582_b0145","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy","author":"Marian","year":"2017","journal-title":"Circ Res."},{"key":"10.1016\/j.scr.2024.103582_b0150","doi-asserted-by":"crossref","unstructured":"Marian AJ (2021) Molecular Genetic Basis of Hypertrophic Cardiomyopathy. Circ Res. 2021 https:\/\/doi: 10.1161\/CIRCRESAHA.121.318346.","DOI":"10.1161\/CIRCRESAHA.121.318346"},{"key":"10.1016\/j.scr.2024.103582_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2003.10.012","article-title":"Hypertrophic cardiomyopathy: an important global disease","author":"Maron","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.scr.2024.103582_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.608473","article-title":"A Novel Homozygous Intronic Variant in TNNT2 Associates With Feline Cardiomyopathy","author":"McNamara","year":"2020","journal-title":"Front Physiol."},{"key":"10.1016\/j.scr.2024.103582_b0170","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.4690","article-title":"Cycloheximide (CHX) Chase Assay to Examine Protein Half-life","author":"Miao","year":"2023","journal-title":"Bio Protoc."},{"key":"10.1016\/j.scr.2024.103582_b0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41434-023-00384-3","article-title":"Homology-directed repair of an MYBPC3 gene mutation in a rat model of hypertrophic cardiomyopathy","author":"Nie","year":"2023","journal-title":"Gene Ther"},{"key":"10.1016\/j.scr.2024.103582_b0185","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1684792","article-title":"Mutation-Specific Phenotypes in hiPSC-Derived Cardiomyocytes Carrying Either Myosin-Binding Protein C Or \u03b1-Tropomyosin Mutation for Hypertrophic Cardiomyopathy","author":"Ojala","year":"2016","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.scr.2024.103582_b0195","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"EUROGENE Heart Failure Project. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy","author":"Richard","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.scr.2024.103582_b0205","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.118.034624","article-title":"A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay","author":"Seeger","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.scr.2024.103582_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy","author":"Semsarian","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.scr.2024.103582_b0215","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.00070","article-title":"Maturation of Human Pluripotent Stem Cell-Derived Cerebellar Neurons in the Absence of Co-culture","author":"Silva","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.scr.2024.103582_b0220","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.118.002368","article-title":"Key Value of RNA Analysis of MYBPC3 Splice-Site Variants in Hypertrophic Cardiomyopathy","author":"Singer","year":"2019","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.scr.2024.103582_b0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41525-023-00373-w","article-title":"The burden of splice-disrupting variants in inherited heart disease and unexplained sudden cardiac death","author":"Singer","year":"2023","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.scr.2024.103582_b0050","doi-asserted-by":"crossref","unstructured":"Suay-Corredera C, Pricolo MR, Herrero-Gal\u00e1n E, Vel\u00e1zquez-Carreras D, S\u00e1nchez-Ortiz D, Garc\u00eda-Giustiniani D, Delgado J, Galano-Frutos JJ, Garc\u00eda-Cebollada H, Vilches S, Dom\u00ednguez F, Molina MS, Barriales-Villa R, Frisso G, Sancho J, Serrano L, Garc\u00eda-Pav\u00eda P, Monserrat L, Alegre-Cebollada J (2021) Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy. J Biol Chem. doi:10.1016\/j.jbc.2021.100854.","DOI":"10.1101\/2020.05.04.20087726"},{"key":"10.1016\/j.scr.2024.103582_b0240","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-11159-y","article-title":"Identification of an elusive spliceogenic MYBPC3 variant in an otherwise genotype-negative hypertrophic cardiomyopathy pedigree","author":"Torrado","year":"2022","journal-title":"Sci Rep."},{"key":"10.1016\/j.scr.2024.103582_b0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310510","article-title":"An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy","author":"Tudurachi","year":"2023","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.scr.2024.103582_b0250","doi-asserted-by":"crossref","DOI":"10.1007\/s00439-017-1809-4","article-title":"Deep intronic mutations and human disease","author":"Vaz-Drago","year":"2017","journal-title":"Hum Genet."},{"key":"10.1016\/j.scr.2024.103582_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2021.102489","article-title":"Generation of bi-allelic MYBPC3 truncating mutant and isogenic control from an iPSC line of a patient with hypertrophic cardiomyopathy","author":"Warnecke","year":"2021","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.scr.2024.103582_b0265","doi-asserted-by":"crossref","DOI":"10.3390\/cardiogenetics11020009","article-title":"Pathogenic Intronic Splice-Affecting Variants in MYBPC3 in Three Patients with HypertrophicCardiomyopathy","author":"Wood","year":"2021","journal-title":"Cardiogenetics"}],"container-title":["Stem Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1873506124002800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1873506124002800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:35:04Z","timestamp":1739838904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1873506124002800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":43,"alternative-id":["S1873506124002800"],"URL":"https:\/\/doi.org\/10.1016\/j.scr.2024.103582","relation":{},"ISSN":["1873-5061"],"issn-type":[{"value":"1873-5061","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-derived induced pluripotent stem cells to study non-canonical splicing variants associated with Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Stem Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scr.2024.103582","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103582"}}